Biotech

All Articles

Zephyrm seeks Hong Kong IPO to cash stage 3 cell therapy trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, declaring (PDF) for an ...

Frazier Life Sciences collects $630M for little, mid-cap biotechs

.Frazier Life Sciences has actually sourced an additionally $630 million for its own fund focused on...

GigaGen gets around $135M BARDA money to hammer botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its ow...

GPCR company Septerna apply for IPO on stamina of preclinical information

.Septerna is about to figure out exactly how a biotech without "any kind of relevant medical records...

Kurma closes first $154M haul for most significant biotech fund yet

.European VC firm Kurma Partners has actually unveiled its own most current biotech fund, with 140 t...

Prothena promotes one exec while yet another keeps-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shootings...

Editas profit Tip Cas9 licensing liberties for $57M

.Against the backdrop of a Cas9 license battle that declines to perish, Editas Medication is cashing...

Ultragenyx adjusts gene therapy application to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have gone ove...

Biopharma unemployment cost supports in Q3: Brutal Biotech study

.As summer heat looks to cool down winds, wishes that this year will bring widespread market relief ...

J &amp J goes down phase 2 dengue candidate in latest shift from injections

.Johnson &amp Johnson's deprioritization of its own infectious condition pipeline has stated an addi...